Assessment of The Effect of Milk_Aftimoon on Melasma
Phase 3
- Conditions
- Melasma.Melasma
- Registration Number
- IRCT2016030826967N1
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
Patients with Melasma who would like to participate in the study including men and women aged 18 to 65 years with duration of the disease more than 6 months.
Exclusion criteria: breastfeeding; pregnancy; intolerance to milk; hormonal disorders (Cushing, Hyperthyridism, Addisons Disease); use of anti stain drugs in the past three months; performance of procedures using chemical peels; microderm abrasion done in the last three months; performance of laser thrapy in the last three months; carrying out intense sun tanning or sunburns in three recent months; suffering from hemorroids; pulmonary problems; taking medicine for other disease.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Dermacatch Changes. Timepoint: Before Treatment, One and Three Months After Begining treatment. Method of measurement: Erythma and Melanin Determinding by Dermacatch.
- Secondary Outcome Measures
Name Time Method Clinical Disease Progression. Timepoint: Before Treatment One and Three Month After Begining treatment. Method of measurement: Targeted Assessment Practitioner(with Comparisons and Review Photo).;MASI Score. Timepoint: Before Treatment, One and Three Months After Begining of Treatment. Method of measurement: Erythema and Color Measurment by Physician.